Evidence map›Paper›PMID 39302382›Full record

ArticleJournal of Parkinson's disease2024

Advancing Parkinson's Disease Research in Canada: The Canadian Open Parkinson Network (C-OPN) Cohort.

Marisa Cressatti, Gabriel D Pinilla-Monsalve, Mathieu Blais, Catherine P Normandeau, Clotilde Degroot, Iris Kathol, Sarah Bogard, Anna Bendas, Richard Camicioli, Nicolas Dupré and 12 more

Abstract read
In one paragraph

Article in Journal of Parkinson's disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Weighing Open Science Against Research Participation Burden in Informed Consent: A Randomized Pilot Study.Journal of empirical research on human research ethics : JERHRE · 2025
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Marisa CressattiDepartment of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada.
Gabriel D Pinilla-MonsalveCentre de Recherche de l'Institut universitaire de gériatrie de Montréal, Montréal, QC, Canada.
Mathieu BlaisAxe Neurosciences du Centre de recherche du CHU de Québec - Université Laval, Québec, QC, Canada.
Catherine P NormandeauDepartment of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada.
Clotilde DegrootMcGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.
Iris KatholDepartment of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada.
Sarah BogardMcGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.
Anna BendasCentre de Recherche de l'Institut universitaire de gériatrie de Montréal, Montréal, QC, Canada.
Richard CamicioliDepartment of Medicine, Division of Neurology, University of Alberta, Edmonton, AB, Canada.
Nicolas DupréAxe Neurosciences du Centre de recherche du CHU de Québec - Université Laval, Québec, QC, Canada.
Ziv Gan-OrMcGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.
David A GrimesDivision of Neurology and Program in Neuroscience, The Ottawa Hospital, University of Ottawa Brain and Mind Research Institute, Ottawa, ON, Canada.
Lorraine V KaliaKrembil Research Institute, Toronto Western Hospital, University Health Network, Toronto, ON, Canada.
Penny A MacDonaldBrain and Mind Institute, University of Western Ontario, London, ON, Canada.
Martin J McKeownPacific Parkinson's Research Centre, Djavad Mowafaghian Centre for Brain Health, University of British Columbia & Vancouver Coastal Health, Vancouver, BC, Canada.
Davide MartinoDepartment of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada.
Janis M MiyasakiDepartment of Medicine, Division of Neurology, University of Alberta, Edmonton, AB, Canada.
Michael G SchlossmacherDivision of Neurology and Program in Neuroscience, The Ottawa Hospital, University of Ottawa Brain and Mind Research Institute, Ottawa, ON, Canada.
A Jon StoesslPacific Parkinson's Research Centre, Djavad Mowafaghian Centre for Brain Health, University of British Columbia & Vancouver Coastal Health, Vancouver, BC, Canada.
Antonio P StrafellaMorton and Gloria Shulman Movement Disorder Unit and the E. J. Safra Parkinson Disease Program, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, ON, Canada.
Edward A FonMcGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.
Oury MonchiDepartment of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Enhancing the interactions between study participants, clinicians, and investigators is imperative for advancing Parkinson's disease (PD) research. The Canadian Open Parkinson Network (C-OPN) stands as a nationwide endeavor, connecting the PD community with ten accredited universities and movement disorders research centers spanning, at the time of this analysis, British Columbia, Alberta, Ontario, and Quebec. Objective: Our aim is to showcase C-OPN as a paradigm for bolstering national collaboration to accelerate PD research and to provide an initial overview of already collected data sets. Methods: The C-OPN database comprises de-identified data concerning demographics, symptoms and signs, treatment approaches, and standardized assessments. Additionally, it collects venous blood-derived biomaterials, such as for analyses of DNA, peripheral blood mononuclear cells (PBMC), and serum. Accessible to researchers, C-OPN resources are available through web-based data management systems for multi-center studies, including REDCap. Results: As of November 2023, the C-OPN had enrolled 1,505 PD participants. The male-to-female ratio was 1.77:1, with 83% (n = 1098) residing in urban areas and 82% (n = 1084) having pursued post-secondary education. The average age at diagnosis was 60.2±10.3 years. Herein, our analysis of the C-OPN PD cohort encompasses environmental factors, motor and non-motor symptoms, disease management, and regional differences among provinces. As of April 2024, 32 research projects have utilized C-OPN resources. Conclusions: C-OPN represents a national platform promoting multidisciplinary and multisite research that focuses on PD to promote innovation, exploration of care models, and collaboration among Canadian scientists.

Indexed as

Parkinson DiseaseAgedBiomedical ResearchCanadaCohort StudiesDatabases, FactualFemaleHumansMaleMiddle AgedCanadacohortopen scienceParkinson’s diseaseresearch platform

Identifiers

PMID39302382
PMCPMC11492019

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.